Pharmena S.A. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was PLN 3.63 million compared to PLN 3.3 million a year ago. Net loss was PLN 0.171 million compared to PLN 0.568 million a year ago. Basic loss per share from continuing operations was PLN 0.02 compared to PLN 0.05 a year ago. Diluted loss per share from continuing operations was PLN 0.02 compared to PLN 0.05 a year ago.